Hanusch Hospital

Vienna 1140

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis of Native Arteries of the Extremities, MDS, MPN (Myeloproliferative Neoplasms), Myelodysplastic Syndrome, RAEB, Refractory Anemia With Excess Blasts

Studies at this site

• ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent — Completed
• Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA — Stopped early
• A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis — Completed